Novartis Investigative Site

Meibergdreef 9 1105 AZ

0 studies enrolling now · 2 studies all time

What they study most

Familial Chylomicronemia Syndrome (FCS), Familial Chylomicronemia Syndrome (FCS) (HLP Type I)

Studies at this site

• Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome. — Stopped early
• A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome — Completed